Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SLP-HPV-01 for Anal Intraepithelial Neoplasia in HIV+ Men
NCT01923116Phase 2Completed
- Sponsor
- University of Amsterdam
- Start
- Aug 2013
- Primary completion
- Jun 2017
- Modality
- Peptides, Peptide-based Cancer Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of SLP-HPV-01 in anal intraepithelial neoplasia (AIN), sponsored by University of Amsterdam. Started Aug 2013; status: completed.
02
Drugs
SLP-HPV-01
03
Conditions
anal intraepithelial neoplasia (AIN)
Beyond the preview
Go deeper on NCT01923116.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01923116.